FELODIPINE AZN ER felodipine 5 mg extended release tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

felodipine, Quantity: 5 mg

Available from:

AstraZeneca Pty Ltd

Pharmaceutical form:

Tablet, modified release

Composition:

Excipient Ingredients: Carnauba Wax; hypromellose; iron oxide red; propyl gallate; macrogol 6000; microcrystalline cellulose; sodium stearylfumarate; iron oxide yellow; lactose; titanium dioxide; PEG-40 hydrogenated castor oil; hyprolose; aluminium sodium silicate

Administration route:

Oral

Units in package:

30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Hypertension

Product summary:

Visual Identification: Circular, pink, biconvex film-coated tablet. A/FM impressed on one side and 5 on the other side; 9mm diameter; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2023-07-27